Inspection of U.S. FDA at the Company''s Pithampur Unit-2 manufacturing facility.

Notice of postal ballot (through remote e-voting).

Amendment to Code of practices and procedures for fair disclosure of unpublished price sensitive information of the Bank

Intimation of Schedule of Analysts / Institutional Investors Meeting to be held on July 22, 2025 at 05:30 P.M. for Earnings Call presentation of Q1 FY26

Resignation of Mr. Ravi Ashok Jakhotia from the position of the General Manager Finance and Admin of the Company

Audio recordings of earnings call with analysts and investors under Regulation 30 of SEBI (LODR)

Updates

Certificate under Regulation 74(5)